Multi-center Study on CCeLL-In Vivo's Clinical Efficacy for Intraoperative Brain Tumor Diagnosis.

Trial statusNot yet recruiting
Trial phasePhase 1
Trial typeInterventional
Biological sexAll
Age18+
SponsorVPIX Medical

About this trial

The primary objective of this study is to demonstrate the non-inferiority of cCeLL compared to frozen section analysis. The investigational device is intended for use with indocyanine green (ICG) for fluorescence imaging as an aid in the visualization of vessels (micro- and macro-vasculature) blood flow in the cerebrovascular before, during or after cranial diagnostic and therapeutic procedures, such as tumor biopsy and resection, which is then read and analyzed by trained-professional for intraoperative diagnosis. The comparison will be held by the device with the conventional intraoperative histological frozen section analysis of identical brain tissue samples in the same patient. Both methods will be compared in terms of their accuracy using the standard of practice, the final pathological diagnosis.

Eligibility criteria

Qualifiers

Male or female patients aged 18 years or older

Patients suspected of having a brain tumor who are scheduled for neurosurgery and are considered candidates for tumor resection

Patients who understand and have signed the informed consent form

Specimens obtained from patients who have agreed to participate in this clinical trial and who meet the inclusion criteria

Disqualifiers

Patients undergoing multiple surgeries

Patients with bacterial or viral infections

Patients who develop allergic reactions to the investigational medical device

Patients with a history of allergy to Indocyanine Green (ICG)

Trial design

Treatments tested in this trial

  • cCeLL In vivo
  • Indocyanine Green

Treatment groups

100 Participants
are divided into 1 treatment group

Locations

This trial has no locations

Sponsors and collaborators